Dalfampridine Effects Beyond Walking Speed in Multiple Sclerosis

Background: Dalfampridine extended release (ER) improves walking in people with multiple sclerosis (MS), as demonstrated by walking speed improvement. This exploratory study evaluated treatment effects of dalfampridine-ER on gait, balance, and walking through treatment withdrawal and reinitiation. M...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Int J MS Care
Prif Awduron: Fjeldstad, Cecilie, Suárez, Gustavo, Klingler, Michael, Henney, Herbert R., Rabinowicz, Adrian L., Pardo, Gabriel
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: The Consortium of Multiple Sclerosis Centers 2015
Pynciau:
Articles
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4673920/
https://ncbi.nlm.nih.gov/pubmed/26664333
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7224/1537-2073.2014-036
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg